Today is my 40th birthday. Almost twelve years ago I was diagnosed with aggressive triple negative
#breastcancer
. The statistics were terrifying. But thanks to scientific research, I am still here.
Please, donate to cancer research if you are able. You can save lives too.
The final big equipment has arrived! The space is starting to look like a real lab now. 🧪 🧫 🥼
Check out our lab website to learn more about our research projects and open positions:
Who has a 3D printer/MakerBot and wants to help protect the caregivers on the front lines of the COVID-19 effort? My brilliant and creative uncle designed face shields you can print and donate to hospitals. Download the template and instructions here:
I’m thrilled to finally be able to share that this story is in press! Thanks to the whole team for all their hard work getting this research out despite all the hurdles the pandemic threw at us. Now back to work on bringing it to patients.
#IO
#ovca
New
#JITC
short report: Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy
@immunegirl
Really excited to share our pre-print that is available today! T cells engineered to convert a death signal into a survival signal have improved persistence and anti-tumor efficacy in a mouse model of advanced ovarian cancer.
@HutchGreenberg
@fredhutch
Oda
@shannonkoda
, Greenberg
@HutchGreenberg
@immunegirl
et al. say that a Fas-4-1BB immunomodulatory fusion protein converts a pro-death to a pro-survival signal, enhancing T cell function and improving the efficacy of adoptive T cell therapy
#Solidtumors
While we've been hard at work for a while, today we were all finally together in the lab for the first time! Thanks Kara, Gabe and Anders for bringing the lab to life!
#newPI
#proudPI
#LookAtThoseBeautifulIncubators
So excited to be here (vaccinated) at the
@sitcancer
Annual Meeting to meet with my rockstar colleagues who are the future of cancer immunotherapy!
#SITC2021
#ECR
@sitcancerECS
My lab will focus on developing immunotherapies that overcome immune suppression in solid tumors, with a focus on engineered adoptive T cell therapy for
#ovariancancer
. Lab website and info about available positions coming soon!
#IO
#TME
Thrilled to be part of this collaboration! T cells struggle to persist and retain function in hostile tumor microenvironments. Engineering T cell metabolism may be one really important component to building better cancer therapies for patients.
Day 1 of the Arthur and Sandra Irving Cancer Immunology Symposium was a productive day full of inspirational stories and motivational advice for launching a successful research lab. Honored to be part of this
#IO
community!
We are so excited to welcome our first graduate rotation students to the lab! They are spending six weeks learning how to engineer human T cells to recognize and kill cancer cells. Meet Yaning Li and Bryce Murillo!
@MedicineUVA
@UVAimmunology
@uva_bims
Thrilled to be back in Boston with these fantastic colleagues for
@sitcancer
#SITC22
#Sparkathon
! Thanks to the organizers and faculty for a great day of programming!
I’m humbled to be part of this wonderful team of advocates who are working every day to ensure patient voices are actively included in
#ovariancancer
research. Science is better because of these collaborations.
Powell-Drescher Ovarian Cancer Research Foundation
A huge welcome to Dr. Anders Nelson, a new
#Postdoc
member of the Anderson lab. Anders recently received his PhD in Pharmacology and will apply his systems biology background to interrogate how engineered T cells interact with other cell types in the
#TME
. Welcome
@andersrnelson
!
I'm really excited to share this news: Next summer, I'll be part of
@ldtimmerman
's
@climbtofight
team! We're tackling Kilimanjaro to raise $1M for cancer research
@fredhutch
. Check out who my fellow climbers will be and consider joining us if you are able!
Thank you
@jitcancer
for the shoutout! I’m proud to be part of the immunotherapy field and grateful to the mentors who continue to support and inspire me.
#IO
#InternationalWomensDay2023
In honor of
#InternationalWomensDay
, we recognize
#JITC
Social Media Editor, Dr. Kristin Anderson (
@immunegirl
). From highlighting
#ECRs
in Meet the Author features to driving engagement in tweetorials, her enthusiasm to connect the field shines bright! 👏
So grateful to the mentors, collaborators and sponsors who supported my application, and to the NCI reviewers for their confidence in my ideas and abilities. I'm thrilled to be able to take this research project to the next level! 🥳👩🔬🧪🔬
November is one of my favorite times of year because
@sitcancer
has an annual opportunity for me to talk about science and life with pretty amazing people.
#ECR
@sitcancerECS
#sparkathon
I love listening to
@EJohnWherry
speak. His elegant studies have contributed so much to our understanding of T cell exhaustion and how to enhance the efficacy of immune-based therapies. Congrats on the well-deserved
#AACR23
Lloyd J. Old Award in Cancer Immunology!
@AACR
Excited to share our newest findings developing engineered T cells to treat
#ovariancancer
. Join us for the cellular therapies session at
#SITC21
today!
This week we are celebrating two milestones: rotation completion and a new lab member! Congratulations Yaning Li and Bryce Murillo for being the first to successfully engineer T cells in a new lab! And welcome to Monica Rodrigues de Jesus, a new scientist in the
@JustinTaylorLab
Excited to be back in DC for
#AAI2023
! I’ll be chairing the “Immunometabolism and anti-tumor immunity” session Friday morning at 10:15 with Dr. Kyle Payne and presenting a poster on Saturday afternoon. Come say hi!
@ImmunologyAAI
I’m honored to be part of this fantastic
@sitcancer
#Sparkathon
team!
Immunotherapy has improved outcomes for many cancer patients, but not all. We propose that multiple immune resistance mechanisms need to be addressed concurrently to improve therapy efficacy. Check it out ⬇️
Good morning
#Boston
- thanks for hosting us for the Irving Cancer Immunology Symposium. I’ve been looking forward to this opportunity to connect with new (and longtime) colleagues, friends and mentors for months!
#IO
#TeamScience
#ECR
It was fun hearing Dr. Mukherjee discuss his science and his thoughts on writing Emperor of All Maladies! Thank you
@fredhutch
for inviting such a cool speaker!
Thanks
@OncologyTimes
for sharing my story and my work. We’re getting closer to making engineered adoptive T cell therapy work against a variety of solid tumors every day!
Just two dedicated
#ECR
preparing to co-chair the basic science rapid oral abstract session at
#SITC22
! The presenting scientists have some exciting stories to share - Come hear about their work on Friday in Ballroom East at 12:10pm.
@scharpingne
@sitcancerECS
I'm honored to be on the virtual hill today with
#OvarianCancer
patients, their families and
@ocrahope
to
#advocate
for federal funding for
#ovca
education and awareness, genetic testing for high-risk individuals, clinical trial access, and scientific research!
#tealaction
Hello San Diego - Thank you for hosting
#SITC23
! Looking forward to cutting-edge immunotherapy research updates, professional development activities and reconnecting with many great friends and colleagues! ☀️ 🧪 👩🔬 🍷
Scientists often have a personal reason (or many) for doing
#CancerResearch
. Mine is from my cancer journey - I want to help others who have to navigate that difficult road.
#Immunotherapy
is one way I am choosing to
#PayItForward
. Thanks for the support!
Here we go! Gearing up for a great
#SITC2019
starting with
@sitcancer
and the World Immunotherapy Council’s 3rd Young Investigator Symposium. Honored by the opportunity to speak as a SITC representative!
For those who haven’t been yet, the
@sitcancer
#WIN
Leadership Institute is a great workshop for Women in
#IO
to network and learn helpful tips for success in the field. Keep an eye out for the 2022 application! Thanks to Lisa Butterfield and the amazing program mentors!
One of my favorite parts of the
@AACR
Annual Meeting is recognizing the scientists who have contributed so much to our collective understanding of cancer and how to treat it. Thank you for dedicating your careers to saving lives!
#gratitude
#AACR23
It was such fun to work with
@AACR
and the
#AACRSSP
to connect Susun and Deborah, research advocates from
@PowerOvarian
, with fellow advocates and scientists from around the world. We’ve learned so much at
#AACR23
and are excited to share it with our communities!
Engineering B cells: a future alternative to vaccination? Great work from the
@FredHutch
Check in out! B cells engineered to express pathogen-specific antibodies using CRISPR/Cas9 protect against infection
Excited to leave for
#CICON
2023 in
#Milan
! The International Cancer Immunotherapy Conference is a great venue to learn about
#IO
research in Europe, reconnect with great friends, and start new collaborations. Looking forward to talking science! 👩���🔬
Very cool finding that T cells cultured with specific lipids can modulate T cell metabolism and anti-tumor function. Excited to read the paper - Great work Teresa Manzo!
#SITC21
Throwback to the
#SITC18
Presidential session when fellow
#ECR
@claycaoyu
and I got to present (and met for the first time). Big thanks to
@sitcancer
for the opportunity that brought us together as friends! It’s such a privilege to “grow up” together!
#SITC22
Just finished a great discussion with
@PattyMurray
and her team about strong support for NIH and cancer research. Thank you for your time and all your hard work!
#AACRECR18
#AACRontheHill
It's that time of year again: the 2021
#SITCFellowship
applications are open (due 4/2/2021). Domestic and international early career investigators from academia and government can apply for $450,000 in fellowship opportunities from
@sitcancer
!
Thank you
@komonews
and
@deniseonKOMO
for sharing my story and helping me honor my dear friend Joyce, whose life was stolen by breast cancer. New therapies cannot come soon enough. Thank you
@ldtimmerman
,
@climbtofight
, and
@fredhutch
for the opportunity to find cures faster!
She's a triple-neg breast cancer survivor. A SITC award-winning young investigator
@fredhutch
. Now Kristin Anderson reached the summit of Kilimanjaro (19,341 ft) to raise $ for cancer research. WATCH the
@immunegirl
story by
@deniseonKOMO
(2:15 TV spot)
Excellent and exciting presentations by the next generation of scientists at the undergraduate poster session. Thanks for all your hard work and for traveling to share it with us at
#AACR22
!
The next generation of cancer scientists is at
#AACR22
. More than 50 undergraduate students present their research to AACR member judges in today's poster competition.
The first day of
#CICON23
was bookended with talks by two luminaries in the field,
@JimAllisonPhD
and Dr. Tak Mak. It was inspiring to start and end the day with great science AND advice about the importance of passion, perseverance & the collaboration.
I congratulate Dr. Jaffee on her appointment to chair the President’s Cancer Panel, and I commend President Biden on his excellent choice to lead the reignited Cancer Moonshot.
📣 Check out our newest episode!
Dr. Kristin Anderson (
@ImmuneGirl
) from
@UVA_MIC
talks about strategies for targeting
#OvarianCancer
, how her cancer diagnosis changed her research focus, and her transition from postdoc to professor.
Listen now:
I'm honored to be part of this
@climbtofight
team.
I often work over the holidays (which can be lonely), but in 2017 I met
@ldtimmerman
randomly in a
@fredhutch
coffee shop.
#worthit
We've raised $1M for cancer research - can you help us make it $1.3M?
Read about my chance meeting
@fredhutch
with
@immunegirl
after Christmas 2017. She's working on T-cell engineering for ovarian cancer. She's also training for Kilimanjaro
@climbtofight
-- part of a team that's raised $1m and counting for cancer research.
Grateful to be part of the "Becoming a Resilient Scientist" series hosted by the
@NIH_OITE
.
@SHARONMILGRAM
challenged us to make a
#WellnessCollage
of non-work things that make us happy. Many things bring me joy, especially family, friends, pets & traveling. What brings you joy?
I am so proud to be represented by this outstanding group of
#ECRs
at
#AACRontheHill
! Thank you for sharing your stories about how cancer has touched your lives - and thank you for the work you do every day to eradicate it from ours.
#AACRECR20
Today dozens of undergraduate researchers are presenting their science today at the
#AACR23
poster competition. They never cease to impress -the future of cancer research is bright!
@AACR
#AACRScholars
#AACRECR
“Mentoring is necessary, but not sufficient. Sponsorship is critical.” Great presentation on shattering the glass ceiling by
@ELTravisPhD
at the
#SITCWIN
Leadership Institute!
@sitcancer
So excited for this new program to support diversity in clinical trials. Congratulations Dr. Winn,
@bmsnews
and
@AACR
on the establishment of this important initiative that will surely improve patient outcomes!
#AACR22
Looking forward to Dr. Michel Sadelain’s talk at
#AACR22
on overcoming antigen escape. Fun Science History Fact: He first coined the term “chimeric antigen receptor”!
#MSKCC
Thank you to the
@UVACancerCenter
for the opportunity to share the goals of the lab's research program and our progress since joining
@MedicineUVA
@UVA_MIC
&
@UVAimmunology
. Great questions and discussion from the audience - I can't wait to see how our science grows here!
Come to the UVA Cancer Center Seminar today at 12:30pm- MIC faculty member Kristin Anderson talks about 'Engineering Adoptive T Cell Therapy to Overcome Immune Suppression in Solid Tumors”
@immunegirl
@UVAimmunology
@UVACancerCenter
Thank you, Dr. Margaret Foti, for spending time at
#AACR23
discussing issues facing
#AACRECR
and helping the
#AACRAMC
develop programming for early career cancer researchers from around the world. We appreciate your time and efforts!
Thanks
@NCICancerBio
for the overview of NIH funding mechanisms and tips for
#ECR
to leverage their ESI status for research success. Check out the CSR opportunity to learn more about NIH study sections from the reviewer perspective.
@sitcancerECS
#SITC2022
#GWW
Another excellent presentation in the
#SITC22
Presidential Session by Dr. Shelley Herbrich (
@smherbrich
) from
@MDAndersonNews
. She shows elegantly that heterozygous Tet2 expression in monocytes influences T cell responses to
#ICB
.
@PamSharmaMDPhD
“One study... looked at the effect of probiotics on the immune system, and found that cancer patients taking these supplements were less likely to respond to immunotherapy” Thanks for doing such important work
@JenWargoMD
@MDAndersonNews
@parkerici
#TheMoreYouKnow
Getting ready for
#HHMT2019
with an incredible line up of ovarian cancer researchers. Thank you for including me
@OvarianCancerUK
- I’m honored and humbled to be part of this group!
The deadline for this leadership event has been extended to March 23rd. I attended last year and have already benefited immeasurably. I strongly encourage all fellow women in
#immunotherapy
research to apply and attend!
#SITCWIN
Apply by March 9 for an opportunity to attend SITC's Women in Cancer Immunotherapy Network Leadership Institute, a FREE program for female leaders in the cancer immunotherapy field, July 13–14 in
#Seattle
and Aug. 3–4 in
#Chicago
.
#SITCWIN
Learn more at
If you want to be part of a fun and dynamic group of future leaders in Immuno-oncology, apply to join the
@sitcancerECS
! We create career development programming for trainees year-round, including at the
@sitcancer
Annual Meeting.
If you want to get involved in the SITC society, the early career scientists committee has one opening ! If you are interested, check out the volunteer opportunity webpage and apply ! Deadline is mid-December 👇🏻👇🏻👇🏻
The specific aims page is your opportunity to inspire the reviewers to be champions of your grant. Make your science shine ✨
#AACR23
#GrantWritingWorkshop
#ECR
Congratulations to
#AACR22
#ECR
,
#AACRAMC
Chair-elect, and Scholar-In-Training Award Recipient
@francescocay
on your award and great poster! Excited for your leadership of the
@AACR
Associate Membership!
I didn’t realize how much I missed my
@fredhutch
#ClimbToFightCancer
crew until we reunited this week in Seattle. Thanks for the adventure,
@ldtimmerman
! Looking forward to many more alumni reunion hikes!
Cheering on fellow
#Sparkathon
participant and
@sitcancerECS
member
@blhorton
during his oral presentation at
#SITC22
. Exciting to see
#ECR
on the big stage! Congrats on an interesting scientific story and a great talk!
I’m honored to be included in this group and I am sincerely grateful to the
#OCRA
for the support for our newest research project:
#Immunotherapy
for
#ovariancancer
We're pleased to announce that
#OCRA
has just awarded over $5.25 million in new scientific research grants for
#ovariancancer
. Along with our other ongoing grants and programs, in 2019, we are investing nearly $9 million in our fight against this disease:
It is a privilege to be on this amazing committee (
@sitcancerECS
) who put so much care into planning helpful programming for our peers. We hope the sessions today were beneficial! Have ideas for future years? Let us know, or join us!
@sitcancer
@jitcancer